Lisinopril/Torasemide

赖诺普利/托拉塞米

Report date: 2022/03/03 15:55:46

Base Information

Drug NameLisinopril/Torasemide
Drug Alias NameComboLT
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsSodium-(potassium)-chloride cotransporter 2 inhibitors
TargetsAngiotensin-converting enzymeSodium-(potassium)-chloride cotransporter 2
Therapy Area/IndicationsEssential HypertensionHeart Failure
Global Approved IndicationsEssential HypertensionHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2017/09/28
Country/TerritoryEU
CombinationsYes LisinoprilTorasemide
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAccupharma Sp Zoo
China Registration ClassN/A

Develop Information

Active CompaniesAccupharma Sp Zoo
Inactive CompaniesN/A
Active IndicationsEssential HypertensionHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC09BA03
Related LinksN/A